Enliven Therapeutics, Inc. · NASDAQ:ELVN
Garland J. Scott sold 13,000 Enliven Therapeutics, Inc. shares (Form 4)
Traded Oct 1, 2026 · Filed Oct 5, 2026
On Oct 1, 2026, Garland J. Scott (Director) sold 13,000 Enliven Therapeutics, Inc. shares at US$46.67 for US$607K, leaving 0 shares. Filed Oct 5, 2026 (Form 4).
- Sold
- 13,000 shares
- Price
- US$46.67
- Value
- US$607K
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Common Stock | Option exercise | 13,000 | US$15.47 | 13,000 | Direct |
| Oct 1, 2026 | Common Stock | Sale | 13,000 | US$46.67 | 0 | Direct |